Applications of CRISPR-Cas9 Technology in Translational Research on Solid-Tumor Cancers

Area of Science:

• Biomedical research
• Genomics
• Cancer biology

Background:

• CRISPR-Cas9 has revolutionized genome editing since its inception.
• Its applications span disease modeling, gene-phenotype studies, and therapeutic interventions.
• While primarily used in basic research, translation to clinical settings is progressing.

Purpose of the Study:

• To review current and prospective applications of CRISPR-Cas9 in solid tumor research.
• To examine the translational potential of CRISPR-Cas9 from laboratory to clinical practice.
• To identify challenges associated with implementing CRISPR-Cas9 in clinical settings for solid tumors.

Main Methods:

• Literature review of CRISPR-Cas9 applications in solid tumor research.
• Analysis of ongoing translational studies and clinical trials.
• Discussion of technical, ethical, and regulatory hurdles.

Main Results:

• CRISPR-Cas9 is instrumental in creating sophisticated preclinical models of solid tumors.
• The system shows promise for targeted cancer therapies and diagnostics.
• Significant challenges remain in delivery, specificity, and long-term safety for clinical use.

Conclusions:

• CRISPR-Cas9 holds immense potential for advancing solid tumor research and treatment.
• Bridging the gap between basic research and clinical application requires overcoming key obstacles.
• Continued innovation is crucial for realizing the full therapeutic benefits of CRISPR-Cas9 in oncology.